Prospektive NIS of trastuzumab Deruxtecan (T-DXd) for adult patients with advanced HER2-positive gastric or Gastroesophageal junction adenocarcinoma who have received a prior Tratsuzumab based regimen , accompanied by a disease registry of patients treated with conventional therapies in a real world setting

Qualitätssicherung der Therapie des Ovarialkarzinoms (QS-OVAR) 

Evaluation of Clinical Management and Outcome in High Risk or Recurrent Endometrial Cancer - A Real-World Observational Study (QS-Endometrium) 

Prospective study with continuous and fixed-Duration Ibrutinib based First Line Treatment in patients with Chronic Lymphocytic Leukemnia in real world setting

Mammakarzinom des Mannes - Eine prospektive Registerstudie der Universitätsfrauenklinik Magdeburg in Zusammenarbeit mit der GBG (German Breast Group) zur Diagnostik und Therapie des Mammakarzinoms des Mannes

PROVIDENCE - Prospective Non-interventional Study (NIS) to Examine Patient-reported Outcomes and Real-world Clinical Data in Patients With HER2-positive or HER2-low Unresectable or Metastatic Breast Cancer Treated With Trastuzumab Deruxtecan (PROVIDENCE)

Digital Monitoring with Patient-reported outcomes in cancer care: A randomized controlled trial

Retentionsrate von Acalabrutinib in einem nicht-interventionellen Setting